Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03258398
Title A Study to Evaluate eFT508 Alone and in Combination With Avelumab in Subjects With MSS Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Effector Therapeutics

colorectal adenocarcinoma


Avelumab + Tomivosertib


Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Scottsdale Arizona 85259 United States Details
Sarah Cannon Research Institute at HealthONE Denver Colorado 80218 United States Details
Florida Cancer Specialists Sarasota Florida 34232 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Kansas City Research Institute Kansas City Missouri 64131 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from for the field